Targeting microbially-derived juvenile protective factors to resolve neuroinflammation and delirium
针对微生物衍生的青少年保护因子来解决神经炎症和谵妄
基本信息
- 批准号:9977764
- 负责人:
- 金额:$ 16.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-15 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:16S ribosomal RNA sequencingAcuteAddressAdolescentAffectAgeAgingAlzheimer&aposs DiseaseAnesthesia proceduresAntibioticsBehaviorBone RegenerationBrainBrain PathologyChronicClinicalCognitive deficitsCommunitiesComplicationCuesDataDeliriumDementiaDevelopmentDiseaseElderlyEtiologyFecesFractureFunctional disorderGerm-FreeGoalsHealth Care CostsHumanImpaired cognitionIncidenceInfectionInfiltrationInflammationInflammatoryIntestinal permeabilityIntestinesKneeKnee FractureKnowledgeLaboratoriesLeadLength of StayLifeLife ExpectancyLinkLongevityMediatingMicrogliaModelingMolecularMolecular ProfilingMusNerve DegenerationNeurologicNeuronal PlasticityOperative Surgical ProceduresOrganOrthopedic Surgery proceduresOutcomePathogenesisPathologicPatient-Focused OutcomesPatientsPerioperativePositron-Emission TomographyPostoperative ComplicationsPostoperative PeriodPreventive measurePublic HealthRecoveryResearchResourcesRiskRisk FactorsRodentSamplingSocietiesSystemTestingTherapeuticTransplantationWorkage effectage relatedagedaging populationbacterial communitybiobankblood-brain barrier permeabilizationbrain parenchymaclinically relevantcognitive functioncohorteffective therapyfecal microbiotafecal transplantationgut microbiomegut microbiotahuman microbiotaimprovedinnovationknee replacement arthroplastylarge datasetsmacrophagemetabolomicsmicrobialmicrobiomemicrobiotamicrobiota metabolitesmild cognitive impairmentmortalitymouse modelnervous system disorderneurocognitive disorderneuroinflammationneuron lossneurotransmissionnovelnovel strategiesnovel therapeutic interventionolder patientoutcome forecastpost-operative cognitive dysfunctionpostoperative deliriumpreventprotective effectprotective factorsrepairedresilienceresponse
项目摘要
ABSTRACT
Postoperative complications such as delirium represent an immense public health challenge that will continue to
intensify as life-expectancy and the number of surgeries during a lifespan continue to increase. Despite efforts
to optimize preventive measures, the incidence of postoperative delirium can affect up to 87% of older adults,
depending on age and surgical procedures, and remains without an effective treatment. Patients with mild-
cognitive impairment (MCI) are most at risk for developing postoperative delirium. Even routine surgical
procedures such as common knee replacement or fracture repair, may result in life-threatening outcomes
including increased risk for long-term cognitive dysfunction. Thus, new therapeutic strategies are urgently
needed. Our long-term goal is to define novel Juvenile Protective Factors (JPFs) derived from intestinal
microbiota and to determine their capacity to protect against the development and progression of aging-related
neurodegenerative and perioperative disorders. The objective here is to compare molecular signatures in
intestinal microbiome samples from healthy juveniles and patients at risk for developing postoperative delirium,
which includes older adults and adults with MCI. Our central hypothesis is that juvenile-associated intestinal
microbiota generate JPFs that confer resiliency to age-associated neuroinflammation and postoperative delirium.
This hypothesis will be tested by pursuing 2 specific aims: 1) analyze the bacterial communities and their
molecular signatures in juvenile, aged, and MCI fecal samples; and 2) determine the functional impact of different
human microbiota communities on postoperative neuroinflammation and delirium-like behavior. The feasibility of
collecting and analyzing these large datasets and models has been established in our laboratories by a unique
translational team. Our preliminary data provide evidence that specific metabolites, known to protect against
neuronal death, are enriched in feces from juvenile mice. In this innovative approach, we will transplant fecal
samples from donor human juvenile, elderly, or MCI patients into germ-free recipient mice in a clinically-relevant
surgical mouse model of postoperative neuroinflammation and delirium-like behaviors. Our rationale for the
proposed research is that successful completion will demonstrate a novel link between aging-related changes in
microbiota and resiliency to postoperative neuroinflammation and cognitive deficits. This work will be significant
by improving our understanding of how intestinal microbiota control fundamental brain pathology (ie,
neuroinflammation and cogntive decline) that may reveal a unique approach to effective treatment for
perioperative neurologic complications.
摘要
术后并发症,如谵妄,是一个巨大的公共卫生挑战,将继续下去,
随着预期寿命和一生中手术次数的不断增加,尽管努力
为了优化预防措施,术后谵妄的发生率可影响高达87%的老年人,
这取决于年龄和外科手术,并且仍然没有有效的治疗。轻度-
认知功能障碍(MCI)患者发生术后谵妄的风险最大。即使是常规手术
常见的膝关节置换术或骨折修复术等手术可能导致危及生命的结局
包括长期认知功能障碍的风险增加。因此,迫切需要新的治疗策略。
needed.我们的长期目标是确定新的少年保护因子(JPF),来自肠
微生物群,并确定他们的能力,以防止发展和衰老相关的进展,
神经退行性疾病和围手术期疾病。这里的目标是比较分子签名,
来自健康青少年和有发生术后谵妄风险的患者的肠道微生物组样品,
包括老年人和轻度认知障碍患者。我们的中心假设是,青少年相关的肠道
微生物群产生JPF,其赋予与年龄相关的神经炎症和术后谵妄的弹性。
这一假设将通过追求2个具体目标进行测试:1)分析细菌群落及其
在青少年,老年人和MCI粪便样品中的分子特征;和2)确定不同的功能影响,
人类微生物群群落对术后神经炎症和谵妄样行为的影响。的可行性
收集和分析这些大型数据集和模型已经在我们的实验室建立了一个独特的
翻译团队我们的初步数据提供的证据表明,特定的代谢物,已知的保护,
神经元死亡,在幼年小鼠的粪便中富集。在这种创新方法中,我们将移植粪便
将来自供体人类青少年、老年人或MCI患者的样品在临床相关的
术后神经炎症和谵妄样行为外科小鼠模型。我们的理由是,
这项研究的成功完成将证明与衰老相关的变化之间存在一种新的联系,
微生物群和术后神经炎症和认知缺陷的弹性。这项工作将具有重大意义
通过提高我们对肠道微生物群如何控制基本脑病理学的理解(即,
神经炎症和认知能力下降),这可能揭示了一种有效治疗
围手术期神经系统并发症。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol.
- DOI:10.1136/bmjopen-2020-047069
- 发表时间:2021-05-05
- 期刊:
- 影响因子:2.9
- 作者:Tang H;Bohannon L;Lew M;Jensen D;Jung SH;Zhao A;Sung AD;Wischmeyer PE
- 通讯作者:Wischmeyer PE
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Niccolo Terrando其他文献
Niccolo Terrando的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Niccolo Terrando', 18)}}的其他基金
Resolution of postoperative pain by complementary approaches
通过补充方法解决术后疼痛
- 批准号:
9703535 - 财政年份:2020
- 资助金额:
$ 16.1万 - 项目类别:
Targeting microbially-derived juvenile protective factors to resolve neuroinflammation and delirium
针对微生物衍生的青少年保护因子来解决神经炎症和谵妄
- 批准号:
9809289 - 财政年份:2019
- 资助金额:
$ 16.1万 - 项目类别:
Neurovascular dysfunction in delirium superimposed on dementia
谵妄叠加痴呆时的神经血管功能障碍
- 批准号:
10181377 - 财政年份:2017
- 资助金额:
$ 16.1万 - 项目类别:
Neurovascular dysfunction in delirium superimposed on dementia
谵妄叠加痴呆时的神经血管功能障碍
- 批准号:
9919475 - 财政年份:2017
- 资助金额:
$ 16.1万 - 项目类别:
Microglia-Amyloid interactions in delirium superimposed on dementia
小胶质细胞-淀粉样蛋白相互作用导致谵妄叠加痴呆
- 批准号:
10586199 - 财政年份:2017
- 资助金额:
$ 16.1万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 16.1万 - 项目类别:
Operating Grants